|
Volumn 22, Issue 20, 2012, Pages 6509-6512
|
Camptothecins in tumor homing via an RGD sequence mimetic
a
Sigma Tau SpA
(Italy)
|
Author keywords
Anticancer drug delivery system; Camptothecin RGD mimetic conjugate; RGD mimetic and Integrin; Tumor homing; Tumor specific targeting
|
Indexed keywords
ARGINYLGLYCYLASPARTIC ACID;
CAMPTOTHECIN DERIVATIVE;
INTEGRIN;
INTEGRIN RECEPTOR;
IRINOTECAN;
ST 7456CL1;
UNCLASSIFIED DRUG;
VITRONECTIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE METASTASIS;
CELL FUNCTION;
CELL HOMING;
CONJUGATION;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG STABILITY;
DRUG STRUCTURE;
GENE OVEREXPRESSION;
HUMAN;
HUMAN TISSUE;
IC 50;
IN VIVO STUDY;
KIDNEY CARCINOMA;
NONHUMAN;
OVARY CARCINOMA;
PROSTATE CANCER;
RAT;
TARGET CELL;
TARGET CELL DESTRUCTION;
TUMOR CELL;
AMINO ACID SEQUENCE;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
CELL LINE, TUMOR;
DRUG DELIVERY SYSTEMS;
FEMALE;
HUMANS;
INTEGRINS;
MALE;
OLIGOPEPTIDES;
OVARIAN NEOPLASMS;
PROSTATIC NEOPLASMS;
RATS;
RATTUS;
|
EID: 84866729904
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.07.061 Document Type: Article |
Times cited : (16)
|
References (11)
|